Merlin Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Merlin Capital’s Portfolio VRTX Stock Details VRTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$847K	Buy
2023 Q4	$806K	Sell
2023 Q3	$700K	Sell
2023 Q2	$718K	Sell
2023 Q1	$722K	Sell
2022 Q4	$675K	Sell
2022 Q3	$708K	Sell
2022 Q2	$793K	Sell
2022 Q1	$792K	Sell
2021 Q4	$874K	Buy